| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/26/2012 | CN102690259A Compound with function of diuresis, preparation method and functions thereof |
| 09/26/2012 | CN102690221A 改性的拟赖氨酸化合物 Proposed modification of lysine compound |
| 09/26/2012 | CN102690210A Novel crystal form VII of agomelatine, preparation method and application thereof and pharmaceutical composition containing the same |
| 09/26/2012 | CN102690209A Mixed crystal of agomelatine (form-VIII), preparation method and application thereof and pharmaceutical composition containing the same |
| 09/26/2012 | CN102688521A Potato and magnesium sulfate composition wet compressing bag |
| 09/26/2012 | CN102688481A Injection for nourishing myocardium |
| 09/26/2012 | CN102688447A Traditional Chinese medicine for treating palpitation and cardiac pain, and preparation method thereof |
| 09/26/2012 | CN102688411A Chinese medicinal preparation for treating temporal arteritis |
| 09/26/2012 | CN102688407A Chinese medicinal composition for treating chronic heart failure |
| 09/26/2012 | CN102688380A Traditional Chinese medicine composition for treating pulmonary heart disease |
| 09/26/2012 | CN102688369A Medicine for treating hemorrhoids |
| 09/26/2012 | CN102688356A Chinese medicinal oral liquid for easing Qi-deficiency type coronary disease and preparation method |
| 09/26/2012 | CN102688337A Medicinal liquor for regulating qi and blood |
| 09/26/2012 | CN102688311A Traditional Chinese medicine compound preparation with blood pressure reducing function and preparation method thereof |
| 09/26/2012 | CN102688308A Traditional Chinese medicine composition for ischemic stroke treatment as well as preparation method and application thereof |
| 09/26/2012 | CN102688295A Chinese medicine composition for controlling metabolic diseases as well as preparation method and application thereof |
| 09/26/2012 | CN102688289A Traditional Chinese medicine epimedium-red sage root powder for treating coronary atherosclerotic heart disease |
| 09/26/2012 | CN102688288A Traditional Chinese medicine pain-relieving powder for treating coronary atherosclerotic heart disease |
| 09/26/2012 | CN102688287A Traditional Chinese medicine composition for treating ischemic stroke and preparation method and application thereof |
| 09/26/2012 | CN102688276A Extraction method for rhodiola rosea injection with assistance of microwave cell disruption |
| 09/26/2012 | CN102688275A Dogwood kernel extract and application thereof in preparing blood pressure reducing composition |
| 09/26/2012 | CN102688253A Preparation method of liquid injection comprising ephedrine and used for improving cerebral ischemia |
| 09/26/2012 | CN102688245A Stable amlodipine and benazepril medicinal composition and preparation method thereof |
| 09/26/2012 | CN102688242A Novel application of rutaecarpine compound |
| 09/26/2012 | CN102688237A Stable Azelnidipine composition |
| 09/26/2012 | CN102688236A Candesartan cilexetil and amlodipine tablet composition and preparation method thereof |
| 09/26/2012 | CN102688235A Lercanidipine hydrochloride composite tablet, preparation method thereof and application as antihypertensive drug |
| 09/26/2012 | CN102688230A New applciation of procyanidine B2 |
| 09/26/2012 | CN102688212A Isosorbide mononitrate sustained release tablet and preparation method thereof |
| 09/26/2012 | CN102688211A Levocarnitine osmotic pump slow and controlled-release tablet and preparation method thereof |
| 09/26/2012 | CN102688203A Alprostadil freeze-dried powder injection and preparation method thereof |
| 09/26/2012 | CN102688188A maleic acid cinepazide injection and preparation method thereof |
| 09/26/2012 | CN102688186A Medicine composition containing vinpocetine raw material |
| 09/26/2012 | CN102688184A Preparation method of ephedrine hydrochloride injection for improving rat blood rheological obstacle |
| 09/26/2012 | CN102687967A Hypertension medicinal pillow |
| 09/26/2012 | CN102349921B Brand new drug composition and preparation method thereof |
| 09/26/2012 | CN102302740B Preparation method of traditional Chinese medicine used for treating thoracic obstructions caused by yin deficiency of heart and kidney |
| 09/26/2012 | CN102302695B Preparation method of traditional Chinese medicine for treating phlegm turbidity and obstruction chest discomfort |
| 09/26/2012 | CN102296016B Health-care wine containing Shuanghuanglian injection and preparation method thereof |
| 09/26/2012 | CN102293938B Traditional Chinese medicine oral liquid for treating cerebralthrombosis and preparation method thereof |
| 09/26/2012 | CN102266289B Cilnidipine liposome solid preparation |
| 09/26/2012 | CN102228515B Separation and enrichment method of total flavones and total alkaloids of Lotus Plumule |
| 09/26/2012 | CN102204602B Lipid-lowering and antihypertensive health tea and preparation method thereof |
| 09/26/2012 | CN102188440B Preparation method of high-purity breviscapinun material used by breviscapinun injection |
| 09/26/2012 | CN102166208B Lisinopril and hydrochlorothiazide pharmaceutical composition liposome solid preparation |
| 09/26/2012 | CN102144970B Alprostadil lipid nanosphere injection and preparation method thereof |
| 09/26/2012 | CN102140126B Rotundic acid derivative and synthesis method thereof as well as application of rotundic acid derivative in preparing medicament for preventing and curing cardiovascular disease |
| 09/26/2012 | CN102119935B Application of tunicamycin in preparing medicament for treating ischemic cerebral apoplexy |
| 09/26/2012 | CN102068577B Traditional Chinese medicine (TCM) composition and application thereof |
| 09/26/2012 | CN102058835B Chinese medicine composition drop for reducing blood pressure and clearing heat and resisting inflammation and preparation method thereof |
| 09/26/2012 | CN101974089B Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection |
| 09/26/2012 | CN101948498B Pseudo-ginsenoside G2, extraction method and drug application thereof |
| 09/26/2012 | CN101912617B Application of MG53 gene to treatment of insulin resistance, type II diabetes mellitus and related diseases thereof |
| 09/26/2012 | CN101883571B Agent for promoting the secretion of adiponectin and/or inhibiting the decrease in the secretion of adiponectin |
| 09/26/2012 | CN101835483B Treatment of atherosclerosis |
| 09/26/2012 | CN101822749B Medicinal preparation for curing hypertension and hyperlipaemia and preparation method thereof |
| 09/26/2012 | CN101822729B Medicine for treating slow arrhythmia sick sinus syndromes |
| 09/26/2012 | CN101808992B 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 09/26/2012 | CN101791340B Method for purifying active ingredients of compound Naodesheng |
| 09/26/2012 | CN101679243B Atropisomer of pyrrole derivative |
| 09/26/2012 | CN101653410B Lacidipine sustained-release preparation and preparation process thereof |
| 09/26/2012 | CN101502549B Notoginsen triterpenes capsule as well as preparation method thereof and method for measuring content |
| 09/26/2012 | CN101444602B Antelope brain-benefiting mixture |
| 09/26/2012 | CN101443321B Substituted chromanol derivatives and their use |
| 09/26/2012 | CN101128485B Monoclonal antibodies against angiopoietin-like protein 4 (ANGPTL4) |
| 09/26/2012 | CN101128484B Compositions and methods relating to anti IGF-1 receptor antibodies |
| 09/26/2012 | CN101103983B Medicinal composition stabilized by base reagent containing pitavastatin calcium and preparation technology thereof |
| 09/25/2012 | US8273916 Crystal comprising (2R)-2-propyloctanoic acid and amine |
| 09/25/2012 | US8273895 NK1 antagonists |
| 09/25/2012 | US8273855 Nogo, Caspr, F3 NB-3 useful in the treatment of injury and disease to the central nervous system |
| 09/25/2012 | US8273765 Bicyclo-pyrazoles and pharmaceutical compositions comprising them |
| 09/25/2012 | US8273756 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 09/25/2012 | US8273740 antiallergen; not direct way to change nature of immunological response to allergen; G-protein-coupled "chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)" antagonist for prostaglandin PGD2, that mediates PGD2-dependent migration of blood Th2 cells; ; asthma, rhinitis, COPD |
| 09/25/2012 | US8273734 5HT2C receptor modulators |
| 09/25/2012 | US8273713 Dietetics, eating disorders, antidiabetic agents |
| 09/25/2012 | CA2683059C Atropisomer of pyrrole derivative |
| 09/25/2012 | CA2683040C Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 09/25/2012 | CA2516822C Method for preparing acid addition salts of polyacidic basic compound |
| 09/25/2012 | CA2496688C Glycinamide derivatives as raf-kinase inhibitors |
| 09/25/2012 | CA2453295C Novel oligoribonucleotide derivatives for specific inhibition of gene expression |
| 09/25/2012 | CA2389337C Reversibly inactivated acidified plasmin |
| 09/20/2012 | WO2012125957A2 Methods and materials for reducing venous stenosis formation of an arteriovenous fistula or graft |
| 09/20/2012 | WO2012125182A1 Npp1 fusion proteins |
| 09/20/2012 | WO2012125013A1 Herbal polypharmaceutical for preventing and treating atherosclerosis |
| 09/20/2012 | WO2012124978A2 Pharmaceutical composition for treating ischemic diseases, containing conditioned medium obtained through three-dimensional cell culture as active ingredient |
| 09/20/2012 | WO2012124858A1 Pharmaceutical composition with enhanced efficacy for inhibiting angiogenesis |
| 09/20/2012 | WO2012124775A1 Nitrogen-containing saturated heterocyclic compound |
| 09/20/2012 | WO2012124744A1 Nitrogen-containing condensed heterocyclic compound |
| 09/20/2012 | WO2012124696A1 Guanidine compound |
| 09/20/2012 | WO2012124649A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these |
| 09/20/2012 | WO2012124311A1 Novel phenylpyridine derivative and drug containing same |
| 09/20/2012 | WO2012123958A1 Highly pure salts of clopidogrel free of genotoxic impurities |
| 09/20/2012 | WO2012123613A1 Inhibitors of s1p receptors for the treatment of calcific aortic stenosis |
| 09/20/2012 | WO2012123561A2 Agent for prophylaxis and treatment of age-associated diseases and disorders and for prolonging life |
| 09/20/2012 | WO2012123432A1 Sec-hydroxycyclohexyl derivatives as hsl inhibitors for the treatment diabetes |
| 09/20/2012 | WO2012122805A1 Medicine for treating ischemic brain injury and its sequelae and preparation method thereof |
| 09/20/2012 | WO2012122707A1 Quaternary ammonium salt compounds, preparation method, pharmaceutical composition and use thereof |
| 09/20/2012 | WO2012094512A3 Myocardial tissue targeting peptides |
| 09/20/2012 | WO2012068341A3 Wnt1 for treatment of cardiovascular disorders and injuries |
| 09/20/2012 | WO2012050611A3 Aptamers to glycoprotein vi |